Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

THTX

Theratechnologies Inc.

Dec 06 • 04:00PM ET

1.63

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.20	Insider Own	40.01%	Shs Outstand	24.20M	Perf Week	-0.61%
Market Cap	39.45M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	0.00%	Shs Float	14.52M	Perf Month	19.85%
Income	-29.13M	PEG	-	EPS next Q	-0.24	Inst Own	49.49%	Short Float / Ratio	0.23% / 0.13	Perf Quarter	-16.84%
Sales	79.73M	P/S	0.49	EPS this Y	57.80%	Inst Trans	-	Short Interest	0.03M	Perf Half Y	-58.65%
Book/sh	-1.72	P/B	-	EPS next Y	60.19%	ROA	-38.19%	Target Price	6.46	Perf Year	-68.41%
Cash/sh	0.95	P/C	1.72	EPS next 5Y	-	ROE	-	52W Range	0.88 - 4.96	Perf YTD	-53.84%
Dividend	-	P/FCF	-	EPS past 5Y	-20.91%	ROI	-	52W High	-67.14%	Beta	1.32
Dividend %	-	Quick Ratio	0.35	Sales past 5Y	16.06%	Gross Margin	69.70%	52W Low	85.23%	ATR	0.17
Employees	144	Current Ratio	0.42	Sales Q/Q	0.21%	Oper. Margin	-23.57%	RSI (14)	55.81	Volatility	8.32% 11.21%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	90.30%	Profit Margin	-36.54%	Rel Volume	0.00	Prev Close	1.63
Shortable	Yes	LT Debt/Eq	-	Earnings	Sep 26 BMO	Payout	-	Avg Volume	263.33K	Price	1.63
Recom	1.40	SMA20	13.60%	SMA50	7.14%	SMA200	-38.61%	Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-17-22	Initiated	Cantor Fitzgerald	Overweight	$9
Jul-29-21	Downgrade	Canaccord Genuity	Buy → Hold	$8 → $3

Nov-24-23 07:30AM	Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award (GlobeNewswire) +13.33%
Oct-31-23 12:34PM	Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement (GlobeNewswire)
Oct-26-23 09:11AM	Why Is Theratechnologies (THTX) Stock Down 22% Today? (InvestorPlace) -28.05%
08:00AM	Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement (GlobeNewswire)
Oct-25-23 04:13PM	Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement (GlobeNewswire)
07:00AM	Loading…
Oct-24-23 07:00AM	Theratechnologies Announces Operational Update (GlobeNewswire) -10.95%
Oct-19-23 07:30AM	Theratechnologies' Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV (GlobeNewswire)
Oct-16-23 07:30AM	Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon (GlobeNewswire)
Oct-13-23 07:30AM	Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs) (GlobeNewswire)
07:00AM	Theratechnologies Announces Results from Trogarzo (Ibalizumab-uiyk) Intramuscular Administration Study (GlobeNewswire)
Oct-12-23 07:30AM	Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer (GlobeNewswire)
Oct-04-23 07:30AM	Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA (GlobeNewswire)
Sep-26-23 07:47AM	Theratechnologies: Fiscal Q3 Earnings Snapshot (Associated Press Finance) -16.19%
07:30AM	Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates (GlobeNewswire)
Sep-25-23 07:30AM	Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility (GlobeNewswire)
07:00AM	Loading…
07:00AM	Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review (GlobeNewswire)
Sep-20-23 07:00AM	Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 (GlobeNewswire)
Sep-18-23 04:15PM	Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update (GlobeNewswire) -5.15%
Sep-07-23 01:57PM	Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) +28.95%
Sep-05-23 07:00AM	Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights (GlobeNewswire) +9.28%
Aug-30-23 10:34AM	Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide (GlobeNewswire)
Aug-21-23 03:24PM	Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite (PR Newswire)
Aug-05-23 03:30PM	10 Oversold Canadian Stocks To Buy (Insider Monkey)
02:53PM	10 Oversold Global Stocks To Buy (Insider Monkey)
Jul-31-23 07:00AM	Theratechnologies Completes 1-for-4 Reverse Stock Split (GlobeNewswire)
Jul-28-23 04:44PM	Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management (GlobeNewswire) +6.90%
Jul-21-23 07:00AM	Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn (GlobeNewswire) -7.88%
Jul-20-23 07:00AM	Theratechnologies Announces 1-for-4 Reverse Stock Split (GlobeNewswire) -5.67%
Jul-19-23 08:54AM	Theratechnologies (TSE:TH investor five-year losses grow to 88% as the stock sheds CA$16m this past week (Simply Wall St.) -6.57%
Jul-12-23 08:13AM	Theratechnologies: Fiscal Q2 Earnings Snapshot (AP Finance) -7.37%
07:30AM	Loading…
07:30AM	Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
Jun-29-23 07:30AM	Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update (GlobeNewswire) -10.99%
Jun-22-23 07:30AM	Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management (GlobeNewswire)
Jun-12-23 07:30AM	Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial (GlobeNewswire)
Jun-02-23 12:15PM	Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide (GlobeNewswire) +9.90%
May-25-23 05:31PM	Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023 (GlobeNewswire)
May-19-23 05:11PM	Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Theratechnologies Inc. (PR Newswire)
May-09-23 12:01PM	Theratechnologies Reports on its Annual Meeting of Shareholders (GlobeNewswire)
May-04-23 07:30AM	Theratechnologies Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison (GlobeNewswire) +8.58%
Apr-18-23 03:43PM	Theratechnologies Inc.'s (TSE:TH) Business And Shares Still Trailing The Industry (Simply Wall St.)
09:00AM	Theratechnologies Data Presentations at AACR 2023 Showcase Potential of Sudocetaxel Zendusortide as a Single Agent and in Combination with other Anticancer Therapies (GlobeNewswire)
07:30AM	Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference (Newsfile)
Apr-12-23 08:36AM	Theratechnologies: Fiscal Q1 Earnings Snapshot (AP Finance)
07:30AM	Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023 (GlobeNewswire)
Apr-03-23 07:30AM	Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update (GlobeNewswire)
Mar-14-23 06:42PM	Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model (GlobeNewswire) +22.19%
Mar-07-23 06:00AM	Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price (GlobeNewswire)
Mar-02-23 05:14AM	Theratechnologies Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Feb-28-23 07:30AM	Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022 (GlobeNewswire)
06:30AM	Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management (GlobeNewswire)
Feb-22-23 05:30PM	Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV (GlobeNewswire)
Feb-16-23 07:30AM	Theratechnologies Announces Path to Resume TH1902 Clinical Development (GlobeNewswire) +11.92%
Feb-14-23 05:00PM	Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update (GlobeNewswire)
Jan-04-23 07:45AM	Open Letter to Shareholders from CEO Paul Levesque (GlobeNewswire) +12.24%
Dec-23-22 10:10AM	Shareholders in Theratechnologies (TSE:TH) are in the red if they invested five years ago (Simply Wall St.)
Dec-01-22 06:30PM	Theratechnologies Announces Update from Ongoing TH1902 Study (GlobeNewswire)
Nov-17-22 02:09PM	Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says (Benzinga) +12.77%
Oct-26-22 07:30AM	Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays (GlobeNewswire)
Oct-18-22 09:03AM	10 Best Low Price Pharma Stocks To Buy Now (Insider Monkey)
Oct-13-22 07:30AM	Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update (GlobeNewswire)
Oct-12-22 07:30AM	Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium (GlobeNewswire)
Oct-03-22 03:09PM	Theratechnologies Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population (GlobeNewswire)
Sep-26-22 07:30AM	Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire) +8.88%
Sep-19-22 04:15PM	Theratechnologies to Present at the Cantor Oncology, Hematology & HemeOnc Conference (GlobeNewswire) -7.04%
Sep-12-22 07:30AM	Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth (GlobeNewswire) +9.77%
Aug-02-22 07:30AM	Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
Jul-28-22 11:19AM	Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens (GlobeNewswire)
Jul-27-22 06:47PM	Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement (GlobeNewswire)
Jul-16-22 10:33AM	Theratechnologies (TSE:TH) investors are sitting on a loss of 62% if they invested five years ago (Simply Wall St.)
Jul-14-22 12:10PM	Theratechnologies Stock Jumps After Q2 Earnings, FY22 Guidance (Benzinga) +5.85%
07:30AM	Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update (GlobeNewswire)
06:30AM	Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies (GlobeNewswire)
Jul-13-22 07:40AM	Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management (GlobeNewswire)
Jul-12-22 07:30AM	CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal (GlobeNewswire)
Jul-07-22 07:30AM	Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update (GlobeNewswire)
May-31-22 07:32AM	Theratechnologies Announces New Head of Investor Relations (GlobeNewswire) +5.65%
May-10-22 10:48AM	Appointments in Conjunction With Theratechnologies Annual Meeting (GlobeNewswire) +7.26%
07:30AM	Theratechnologies Initiates Basket Portion of TH1902 First-in-Human Study in Advanced Resistant Malignancies (GlobeNewswire)
Apr-29-22 01:24PM	Theratechnologies Inc. (TSE:TH): Are Analysts Optimistic? (Simply Wall St.)
Apr-27-22 07:30AM	THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION ACTIVITIES ON THE NORTH AMERICAN TERRITORY (PR Newswire)
Apr-25-22 04:16PM	Theratechnologies to Present at Bloom Burton & Co. Healthcare Investor Conference 2022 (GlobeNewswire)
Apr-13-22 07:30AM	Theratechnologies Reports Financial Results for First Quarter Fiscal 2022 and Provides Business Update (GlobeNewswire)
Apr-08-22 01:00PM	Theratechnologies Presents New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers AACR Annual Meeting 2022 (GlobeNewswire)
Mar-31-22 05:05PM	Theratechnologies to Announce Financial Results for Its First Quarter 2022 (GlobeNewswire)
Mar-08-22 04:31PM	Theratechnologies to Present Three Posters at AACR Including New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers (GlobeNewswire) -5.09%
Feb-24-22 07:30AM	Theratechnologies Reports Financial Results for Fiscal 2021 and Provides Business Update (GlobeNewswire) -7.69%
Feb-16-22 07:30AM	Theratechnologies Presents Results From Trogarzo® IV Push Administration Study at CROI 2022 (GlobeNewswire)
Feb-15-22 07:30AM	Theratechnologies Strengthens Global Commercial Capabilities by Launching Internal Field Force (GlobeNewswire)
Feb-10-22 07:00AM	Theratechnologies to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2021 (GlobeNewswire)
Jan-26-22 11:46AM	Theratechnologies (TSE:TH) three-year losses have grown faster than shareholder returns have fallen, but the stock pops 11% this past week (Simply Wall St.)
Dec-06-21 11:52AM	Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV (GlobeNewswire)
Nov-26-21 01:06PM	Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category (GlobeNewswire)
Nov-23-21 09:46AM	Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended (PR Newswire)
Nov-03-21 07:30AM	Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 (GlobeNewswire)
Oct-26-21 02:00AM	Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1 (GlobeNewswire)
Oct-22-21 09:15AM	Theratechnologies Announces Publication in Frontiers in Oncology Journal Highlighting SORT1+ Technology for Targeting SORT1-Mediated Vasculogenic Mimicry (GlobeNewswire)
Oct-13-21 07:00AM	Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update (GlobeNewswire)
Oct-06-21 08:30AM	Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference (GlobeNewswire)
Sep-29-21 08:30AM	Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021 (GlobeNewswire)
Sep-22-21 08:08AM	Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study (GlobeNewswire) +5.04%

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

THTX

Theratechnologies Inc.

Upgrade your FINVIZ experience